Close

StemCells (STEM) Gets $20M Award from CIRM for HuCNS-SC Development as Alzheimer's Treatment

September 6, 2012 9:06 AM EDT Send to a Friend
StemCells, Inc. (Nasdaq: STEM) announced that the California Institute for Regenerative Medicine (CIRM) has approved an award to the Company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login